Cargando…
Alloantibody and Autoantibody Monitoring Predicts Islet Transplantation Outcome in Human Type 1 Diabetes
Long-term clinical outcome of islet transplantation is hampered by the rejection and recurrence of autoimmunity. Accurate monitoring may allow for early detection and treatment of these potentially compromising immune events. Islet transplant outcome was analyzed in 59 consecutive pancreatic islet r...
Autores principales: | Piemonti, Lorenzo, Everly, Matthew J., Maffi, Paola, Scavini, Marina, Poli, Francesca, Nano, Rita, Cardillo, Massimo, Melzi, Raffaella, Mercalli, Alessia, Sordi, Valeria, Lampasona, Vito, Espadas de Arias, Alejandro, Scalamogna, Mario, Bosi, Emanuele, Bonifacio, Ezio, Secchi, Antonio, Terasaki, Paul I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3636624/ https://www.ncbi.nlm.nih.gov/pubmed/23274902 http://dx.doi.org/10.2337/db12-1258 |
Ejemplares similares
-
Autologous Pancreatic Islet Transplantation in Human Bone Marrow
por: Maffi, Paola, et al.
Publicado: (2013) -
Co-Graft of Allogeneic Immune Regulatory Neural Stem Cells (NPC) and Pancreatic Islets Mediates Tolerance, while Inducing NPC-Derived Tumors in Mice
por: Melzi, Raffaella, et al.
Publicado: (2010) -
miR-204 is associated with an endocrine phenotype in human pancreatic islets but does not regulate the insulin mRNA through MAFA
por: Marzinotto, Ilaria, et al.
Publicado: (2017) -
No Evidence of Long-Term Disruption of Glycometabolic Control After SARS-CoV-2 Infection
por: Laurenzi, Andrea, et al.
Publicado: (2021) -
Total Pancreatectomy With Islet Autotransplantation as an Alternative to High-risk Pancreatojejunostomy After Pancreaticoduodenectomy: A Prospective Randomized Trial
por: Balzano, Gianpaolo, et al.
Publicado: (2023)